SLC14A1: a novel target for human urothelial cancer

• R. Hou ^[3] ; X. Kong ^[3] ; B. Yang ^[1] ; Y. Xie ^[2] ; G. Chen ^[2]
  1. [1] Peking University

     Peking University

     China

     
  2. [2] Emory University

     Emory University

     Estados Unidos

     
  3. [3] China Japan Union Hospital. Changchun, China

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 12, 2017, págs. 1438-1446
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Urinary bladder cancer is the second commonly diagnosed genitourinary malignancy. Previously, bio-molecular alterations have been observed within certain locations such as chromosome 9, retinoblastoma gene and fibroblast growth factor receptor-3. Solute carrier family 14 member 1 (SLC14A1) gene encodes the type-B urea transporter (UT-B) which facilitates the passive movement of urea across cell membrane, and has recently been related with human malignancies, especially for bladder cancer. Herein, we discussed the SLC14A1 gene and UT-B protein properties, aiming to elucidate the expression behavior of SLC14A1 in human bladder cancer. Furthermore, by reviewing some well-established theories regarding the carcinogenesis of bladder cancer, including several genome wide association researches, we have bridged the mechanisms of cancer development with the aberrant expression of SLC14A1. In conclusion, the altered expression of SLC14A1 gene in human urothelial cancer may implicate its significance as a novel target for research.